Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Hugel Inc (145020 KS)
Watchlist
48
Analysis
Health Care
•
South Korea
Hugel, Inc. is a Bio-pharmaceutical company that focuses on developing beauty/cosmetics related products. The Company's main products include botulinum toxin and fillers.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Hanon Systems
•
22 Dec 2021 06:17
Korea M&A Recap in 2021 - A Leapfrog Year
2021 has been a leapfrog year in terms of major M&As in Korea. Some of the largest M&A deals in 2022 could include Hanon Systems, Bodyfriend,...
Douglas Kim
Follow
315 Views
Share
bearish
•
BNC Korea
•
29 Oct 2021 22:50
BNC Korea (256840 KS): Oral COVID-19 Treatment No More Remains a Catalyst
In-licensed oral COVID-19 treatment no longer remains a catalyst after competitor's encouraging clinical trial results. Other oral treatments are...
Tina Banerjee
Follow
109 Views
Share
bearish
•
Hugel Inc
•
15 Aug 2021 05:44
The Fight to Acquire Hugel - GS Group Led Consortium or Goldman Sachs Led Consortium?
The fight to acquire Hugel Inc (145020 KS) is now finally down to between the GS Group led consortium and the Goldman Sachs led consortium.
Douglas Kim
Follow
406 Views
Share
bearish
•
Hugel Inc
•
29 Jun 2020 18:11
Hugel Placement: A 5.2% Block Deal Sale
After the market close today, it was reported that BK Medical Group’s Chairman Dr. Kim Byung-Gun and Dr. BK Corp will sell their 5.2% stake...
Douglas Kim
Follow
298 Views
Share
bearish
•
Daewoong Pharmaceutical Co
•
28 Mar 2019 07:36
Daewoong: Entering "Botox World"
Daewoong Pharmaceutical Co (069620 KS) has traded up over the past year in anticipation of the launch of its botulinum toxin product Jeuveau in the...
Kemp Dolliver, CFA
511 Views
Share
First
Previous
2
3
4
5
6
7
8
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x